Experienced in Contact Dermatitis

Bin Yang

China P.R, 
Guangzhou, CN 
Experienced in Contact Dermatitis
China P.R, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Bin Yang practices in Guangzhou, China. Mr. Yang is rated as an Experienced expert by MediFind in the treatment of Contact Dermatitis. His top areas of expertise are Primary Localized Cutaneous Amyloidosis, Syphilis, Becker's Nevus, and Keloids.

His clinical research consists of co-authoring 248 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Contact Dermatitis.

Gender
Male

Locations

China P.R, Guangzhou, China
Other Locations
No. 2 Lujing Road, Guangzhou, China
No.2 Lujing Road, Guangzhou, 510000, China
No. 2 Lujing Road, Guangzhou, 510085, China
No. 2 Lujing Road, Guangzhou, 510095, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-blind, Vehicle-Controlled, Phase II/Ⅲ Seamless Adaptive Clinical Trail to Evaluate the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
A Randomized, Double-blind, Vehicle-Controlled, Phase II/Ⅲ Seamless Adaptive Clinical Trail to Evaluate the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
Enrollment Status: Terminated
Publish Date: July 13, 2022
Intervention Type: Drug, Other
Study Drug: SHR0302 Ointment
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

248 Total Publications

Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study.
Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study.
Journal: The Journal of dermatological treatment
Published: December 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yang's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile